Login Register Cart 0
Recent Advances in Food, Nutrition & Agriculture

Recent Advances in Food, Nutrition & Agriculture

Editor-in-Chief

ISSN (Print): 2772-574X
ISSN (Online): 2772-5758

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Redefining Chronic Disease Care: Unleashing the Potential of Phytomedicines

Author(s): Tohfa Siddiqui*, Vikram Sharma, Sakshi Kumar and Komal Gupta

Volume 17, Issue 1, 2026

Published on: 28 October, 2024

Page: [21 - 32] Pages: 12

DOI: 10.2174/012772574X324849240912071511

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Phytomedicines represent a diverse array of plant-derived compounds renowned for their therapeutic potential. Traditionally, these mixtures were extracted using water or ethanol, but simpler methods like tea infusions are gaining prominence. However, ensuring the efficacy and safety of phytomedicines demands high-quality plant material and stringent production processes. Advancements in biological screening techniques have shed light on the mechanisms of action of phytomedicines, emphasizing the significance of synergistic interactions among their constituents. Ten widely-used phytomedicines are outlined, detailing their applications, efficacy, and safety profiles, underscoring their global importance in healthcare. Moreover, ongoing research in phytomedicine development showcases the rich biodiversity's capacity to yield novel medicinal compounds. These studies highlight the potential of untapped plant sources in providing innovative solutions to medical challenges, offering promising avenues for future therapeutics. In essence, the utilization of phytomedicines underscores a fusion of traditional knowledge with modern scientific approaches, emphasizing both the importance of respecting ancient remedies and harnessing contemporary advancements for improved healthcare outcomes.

Keywords: Phytomedicines, plant-derived compounds, screening techniques, cognition, pharmacognosy, traditional medicine.

« Previous Next »

Graphical Abstract

Graphical abstract illustrating key findings of the study

[1]
Chan PC, Xia Q, Fu PP. Ginkgo biloba leave extract: Biological, medicinal, and toxicological effects. J Environ Sci Health Part C Environ Carcinog Ecotoxicol Rev 2007; 25(3): 211-44.
[http://dx.doi.org/10.1080/10590500701569414] [PMID: 17763047]
[2]
El-Sabban F, Abouazra H. Effect of garlic on atherosclerosis and its factors. East Mediterr Health J 2008; 14(1): 195-205.
[PMID: 18557469]
[3]
Emendörfer F, Emendörfer F, Bellato F, et al. Evaluation of the relaxant action of some Brazilian medicinal plants in isolated guinea-pig ileum and rat duodenum. J Pharm Pharm Sci 2005; 8(1): 63-8.
[PMID: 15946599]
[4]
World Health Organization Traditional medicine. Geneva: WHO 2024. Available from: https://www.who.int/news-room/questions-and-answers/item/traditional-medicine [Accessed 26 Aug 2024].
[5]
Hes T, Valešová L, Žiaková M. Proposed institutionalization of a global pro-conservationist second-floor microfinancing system inspired by the nexus between biodiversity, poverty, and population growth: Example of Toba Samosir and Samosir Regency in North Sumatra, Indonesia. Int J Ecol Econ Stat 2017; 38: 28-40. Available from: https://ceser.in/ceserp/index.php/ijees/article/view/4754
[6]
Anke J, Ramzan I. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.). J Ethnopharmacol 2004; 93(2-3): 153-60.
[http://dx.doi.org/10.1016/j.jep.2004.04.009] [PMID: 15234747]
[7]
Fitzpatrick LA. Soy isoflavones: Hope or hype? Maturitas 2003; 44 (Suppl. 1): S21-9.
[http://dx.doi.org/10.1016/S0378-5122(02)00345-6] [PMID: 12609556]
[8]
Butterweck V, Schmidt MSt. John’s wort: Role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr 2007; 157(13-14): 356-61.
[http://dx.doi.org/10.1007/s10354-007-0440-8] [PMID: 17704987]
[9]
Alves RJV, Jotz GP, do Amaral VS, Montes TMH, Menezes HS, de Andrade HHR. The evaluation of maté (Ilex paraguariensis) genetic toxicity in human lymphocytes by the cytokinesis-block in the micronucleus assay. Toxicol In Vitro 2008; 22(3): 695-8.
[http://dx.doi.org/10.1016/j.tiv.2007.11.005] [PMID: 18083001]
[10]
Swiderski F, Dabrowska M, Rusaczonek A, Waszkiewicz-Robak B. Bioactive substances of garlic and their role in dietoprophylaxis and dietotherapy. Rocz Panstw Zakl Hig 2007; 58(1): 41-6.
[PMID: 17711089]
[11]
Bilia AR, Gallori S, Vincieri FF. Kava-kava and anxiety: Growing knowledge about the efficacy and safety. Life Sci 2002; 70(22): 2581-97.
[http://dx.doi.org/10.1016/S0024-3205(02)01555-2] [PMID: 12269386]
[12]
Bagalkotkar G, Sagineedu SR, Saad MS, Stanslas J. Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: A review. J Pharm Pharmacol 2006; 58(12): 1559-70.
[http://dx.doi.org/10.1211/jpp.58.12.0001] [PMID: 17331318]
[13]
Gurib-Fakim A. Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 2006; 27(1): 1-93.
[http://dx.doi.org/10.1016/j.mam.2005.07.008] [PMID: 16105678]
[14]
Calixto JB, Santos ARS, Filho VC, Yunes RA. A review of the plants of the genus Phyllanthus: Their chemistry, pharmacology, and therapeutic potential. Med Res Rev 1998; 18(4): 225-58.https://pubmed.ncbi.nlm.nih.gov/9664291/
[15]
Calixto JB. "Cordia verbenacea." [Cordia verbenacea]. Arquivos Brasileiros de Fitomedicina Científica (Brazilian Archives of Scientific Phytomedicine) 2005; 2: 5-8.
[16]
Emendörfer F, Emendörfer F, Bellato F, et al. Antispasmodic activity of fractions and cynaropicrin from Cynara scolymus on guinea-pig ileum. Biol Pharm Bull 2005; 28(5): 902-4.
[http://dx.doi.org/10.1248/bpb.28.902] [PMID: 15863902]
[17]
Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008; 15(8): 639-52.
[http://dx.doi.org/10.1016/j.phymed.2008.06.008] [PMID: 18599280]
[18]
Heck CI, De Mejia EG. Yerba Mate Tea (Ilex paraguariensis): A comprehensive review on chemistry, health implications, and technological considerations. J Food Sci 2007; 72(9): R138-51.
[http://dx.doi.org/10.1111/j.1750-3841.2007.00535.x] [PMID: 18034743]
[19]
Cechinel Filho V, Yunes RA. Novas perspectivas dos produtos naturais na química medicinal" .[New perspectives on natural products in medicinal chemistry]. In: Química de produtos naturais, novos fármacos e a moderna farmacognosia (In: Chemistry of natural products, new drugs, and modern pharmacognosy),. UNIVALI: Itajaí-SC, Brazil 2007; pp. 11-32.
[20]
Carlini ELA. "Estudo da ação antiúlcera gástrica de plantas brasileiras: Maytenus ilicifolia (Espinheira Santa)." [Study of the gastric anti-ulcer action of Brazilian plants: Maytenus ilicifolia (Espinheira Santa)] Brasília, DF, Brazil: CEME/AFIP 1988.https://www.infraestruturameioambiente.sp.gov.br/institutodebotanica/1988/01/estudo-de-acao-antiulcera-gastrica-de-plantas-brasileiras-maytenus-ilicifolia-espinheira-santa-e-outras/
[21]
Gathirwa JW, Rukunga GM, Mwitari PG, et al. Traditional herbal antimalarial therapy in Kilifi district, Kenya. J Ethnopharmacol 2011; 134(2): 434-42.
[http://dx.doi.org/10.1016/j.jep.2010.12.043] [PMID: 21211554]
[22]
Lampronti I, Khan M, Bianchi N, et al. Bangladeshi medicinal plant extracts inhibiting molecular interactions between nuclear factors and target DNA sequences mimicking NF-kappaB binding sites. Med Chem 2005; 1(4): 327-33.
[http://dx.doi.org/10.2174/1573406054368684] [PMID: 16789890]
[23]
Konkimalla VS, Wang G, Kaina B, Efferth T. Microarray-based expression of DNA repair genes does not correlate with growth inhibition of cancer cells by natural products derived from traditional Chinese medicine. Cancer Genomics Proteomics 2008; 5(2): 79-84.
[PMID: 18460736]
[24]
Cravotto G, Boffa L, Genzini L, Garella D. Phytotherapeutics: an evaluation of the potential of 1000 plants. J Clin Pharm Ther 2010; 35(1): 11-48.
[http://dx.doi.org/10.1111/j.1365-2710.2009.01096.x] [PMID: 20175810]
[25]
Mattoli L, Cangi F, Maidecchi A, et al. Metabolomic fingerprinting of plant extracts. J Mass Spectrom 2006; 41(12): 1534-45.
[http://dx.doi.org/10.1002/jms.1099] [PMID: 17051519]
[26]
van der Kooy F, Maltese F, Choi YH, Kim HK, Verpoorte R. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting. Planta Med 2009; 75(7): 763-75.
[http://dx.doi.org/10.1055/s-0029-1185450] [PMID: 19288400]
[27]
Langfield RD, Scarano FJ, Heitzman ME, Kondo M, Hammond GB, Neto CC. Use of a modified microplate bioassay method to investigate antibacterial activity in the Peruvian medicinal plant Peperomia galioides. J Ethnopharmacol 2004; 94(2-3): 279-81.
[http://dx.doi.org/10.1016/j.jep.2004.06.013] [PMID: 15325731]
[28]
McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 2006; 20(7): 519-30.
[http://dx.doi.org/10.1002/ptr.1900] [PMID: 16628544]
[29]
Piper methysticum (Kava kava) Monograph. Alternative Medicine Review 1998; 3(6): 458-60. Available from: https://altmedrev.com/wp-content/uploads/2019/02/v3-6-458.pdf
[30]
Lemberkovics E, Kéry A, Marczal G, Simándi B, Szöke E. Phytochemical evaluation of essential oils, medicinal plants and their preparations. Acta Pharm Hung 1998; 68(3): 141-9.
[PMID: 9703700]
[31]
Liu K. Soybeans: Chemistry, Technology and Utilization. New York, NY: Chapman & Hall 1997.
[http://dx.doi.org/10.1007/978-1-4615-1763-4]
[32]
Cheng Y, Wang Y, Wang X. A causal relationship discovery-based approach to identifying active components of herbal medicine. Comput Biol Chem 2006; 30(2): 148-54.
[http://dx.doi.org/10.1016/j.compbiolchem.2005.11.003] [PMID: 16542877]
[33]
Wang Y, Wang X, Cheng Y. A computational approach to botanical drug design by modeling quantitative composition-activity relationship. Chem Biol Drug Des 2006; 68(3): 166-72.https://pubmed.ncbi.nlm.nih.gov/17062014/
[PMID: 17062014]
[34]
Messina MJ, Wood CE. Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary. Nutr J 2008; 7: 17.
[http://dx.doi.org/10.1186/1475-2891-7-17] [PMID: 18522734]
[35]
Mariot MP, Barbieri RL. "Metabólitos secundários e propriedades medicinais da espinheira-santa (Maytenus ilicifolia Mart. ex Reiss. e M. aquifolium Mart.)." [Secondary metabolites and medicinal properties of Espinheira Santa (Maytenus ilicifolia Mart ex Reiss and M aquifolium Mart)] Revista Brasileira de Plantas Medicinais (Braz J Medl Plants) 2007; 9: 89-99.https://www1.ibb.unesp.br/Home/Departamentos/Botanica/RBPMRevistaBrasileiradePlantasMedicinais/artigo13_v9_n3.pdf
[36]
Mills SY, Steinhoff B. Kava-kava: A lesson for the phytomedicine community. Phytomedicine 2003; 10(2-3): 261-2.
[http://dx.doi.org/10.1078/094471103321660003] [PMID: 12725583]
[37]
Queiroz MLS, Valadares MC, Torello CO, et al. Comparative studies of the effects of Tabebuia avellanedae bark extract and β-lapachone on the hematopoietic response of tumour-bearing mice. J Ethnopharmacol 2008; 117(2): 228-35.
[http://dx.doi.org/10.1016/j.jep.2008.01.034] [PMID: 18343063]
[38]
Rizzo I, Vedoya G, Maurutto S, Haidukowski M, Varsavsky E. Assessment of toxigenic fungi on Argentinean medicinal herbs. Microbiol Res 2004; 159(2): 113-20.
[http://dx.doi.org/10.1016/j.micres.2004.01.013] [PMID: 15293944]
[39]
Pittler MH, Ernst E. Clinical effectiveness of garlic (Allium sativum). Mol Nutr Food Res 2007; 51(11): 1382-5.
[http://dx.doi.org/10.1002/mnfr.200700073] [PMID: 17918163]
[40]
Setchell KDR, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: Evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003; 78(3) (Suppl.): 593S-609S.
[http://dx.doi.org/10.1093/ajcn/78.3.593S] [PMID: 12936954]
[41]
Santos ARS, Filho VC, Yunes RA, Calixto JB. Analysis of the mechanisms underlying the antinociceptive effect of the extracts of plants from the genus Phyllanthus. Gen Pharmacol 1995; 26(7): 1499-506.
[http://dx.doi.org/10.1016/0306-3623(95)00030-5] [PMID: 8690236]
[42]
Sharangi AB. Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) - A review. Food Res Int 2009; 42(5-6): 529-35.
[http://dx.doi.org/10.1016/j.foodres.2009.01.007]
[43]
Trevisan MTS, Macedo FVV, van de Meent M, Rhee IK, Verpoorte R. “Seleção de plantas com atividade anticolinasterase para tratamento da doença de Alzheimer.” Selection of plants with anticholinesterase activity for the treatment of Alzheimer’s disease. Química Nova (New Chem) 2003; 23: 301-4.
[http://dx.doi.org/10.1590/S0100-40422003000300002]
[44]
Prediger RDS, Fernandes MS, Rial D, et al. Effects of acute administration of the hydroalcoholic extract of mate tea leaves (Ilex paraguariensis) in animal models of learning and memory. J Ethnopharmacol 2008; 120(3): 465-73.
[http://dx.doi.org/10.1016/j.jep.2008.09.018] [PMID: 18948179]
[45]
Noldin VF, Cechinel Filho V, Monache FD, et al. Composição química e atividades biológicas das folhas de Cynara scolymus L. (alcachofra) cultivada no Brasil.” [Chemical composition and biological activities of the leaves of Cynara scolymus L. (artichoke) cultivated in Brazil. Química Nova (New Chem) 2003; 26(3): 331-4.
[http://dx.doi.org/10.1590/S0100-40422003000300008]
[46]
Peter JH. Valerian: The Genus Valeriana. Amsterdam, Netherlands: Harwood Academic Publishers 1997.
[47]
Singh YN. Potential for interaction of kava and St. John’s wort with drugs. J Ethnopharmacol 2005; 100(1-2): 108-13.
[http://dx.doi.org/10.1016/j.jep.2005.05.014] [PMID: 16005588]
[48]
Shale TL, Stirk WA, van Staden J. Screening of medicinal plants used in Lesotho for anti-bacterial and anti-inflammatory activity. J Ethnopharmacol 1999; 67(3): 347-54.
[http://dx.doi.org/10.1016/S0378-8741(99)00035-5] [PMID: 10617071]
[49]
Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94(3): 311-21.
[http://dx.doi.org/10.1016/j.diabres.2011.10.029]
[50]
Peer N, Kengne AP, Motala AA, Mbanya JC. Diabetes in the Africa region: An update. Diabetes Res Clin Pract 2014; 103(2): 197-205.
[http://dx.doi.org/10.1016/j.diabres.2013.11.006]
[51]
Turiák G, Farkasné TI. Problems involved in standardization of flavonoids in crude drugs and extracts from medicinal plants. Acta Pharm Hung 1987; 57(5): 193-8.
[PMID: 3434288]
[52]
Wilt T, Ishani A, Stark G, MacDonald R, Mulrow C, Lau J. Serenoa repens for treatment of benign prostatic hyperplasia (Cochrane Review)The Cochrane Library. Oxford: The Cochrane 1999.
[53]
Wurglics M, Schubert-Zsilavecz M. Hypericum perforatum: A ‘modern’ herbal antidepressant: Pharmacokinetics of active ingredients. Clin Pharmacokinet 2006; 45(5): 449-68.
[http://dx.doi.org/10.2165/00003088-200645050-00002] [PMID: 16640452]
[54]
Zuin VG, Vilegas JH. Pesticide residues in medicinal plants and phytomedicines. Phytother Res 2000; 14(2): 73-88.https://pubmed.ncbi.nlm.nih.gov/10685102/
[PMID: 10685102]
[55]
Wang Y, Tang H, Nicholson JK, et al. Metabolomic strategy for the classification and quality control of phytomedicine: A case study of chamomile flower (Matricaria recutita L.). Planta Med 2004; 70(3): 250-5.
[http://dx.doi.org/10.1055/s-2004-815543] [PMID: 15114503]
[56]
Wagner H. New targets in phytopharmacology of plants. In: Herbal Medicine: A Concise Overview for Professionals. Britain: Butterworth-Heinemann 2000.
[57]
Yadav NP, Pal A, Shanker K, et al. Synergistic effect of silymarin and standardized extract of Phyllanthus amarus against CCl4-induced hepatotoxicity in Rattus norvegicus. Phytomedicine 2008; 15(12): 1053-61.
[http://dx.doi.org/10.1016/j.phymed.2008.08.002] [PMID: 18848770]
[58]
Vacek J, Klejdus B, Kubán V. Hypericin and hyperforin: Bioactive components of St. John’s Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect. Ceska Slov Farm 2007; 56(2): 62-6.
[PMID: 17619301]
[59]
Wagner H, Ulrich-Merzenich G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 2009; 16(2-3): 97-110.
[http://dx.doi.org/10.1016/j.phymed.2008.12.018] [PMID: 19211237]
[60]
Wegener T, Fintelmann V. Pharmacological properties and therapeutic profile of artichoke (Cynara scolymus L.). Wien Med Wochenschr 1999; 149(8-10): 241-7.
[PMID: 10483691]
[61]
Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 2002; 81(1): 81-100.
[http://dx.doi.org/10.1016/S0378-8741(02)00059-4] [PMID: 12020931]
[62]
Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000; 71(1-2): 23-43.
[http://dx.doi.org/10.1016/S0378-8741(00)00213-0] [PMID: 10904144]
[63]
Seth SD, Sharma B. Medicinal plants in India. Indian J Med Res 2004; 120(1): 9-11.
[PMID: 15299226]
[64]
Ramachandran A, Snehalatha C, Viswanathan V. Burden of type 2 diabetes and its complications- The Indian scenario. Curr Sci 2002; 83: 1471-6.
[65]
Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care 2000; 23(8): 1182-6.
[http://dx.doi.org/10.2337/diacare.23.8.1182] [PMID: 10937519]
[66]
Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5(2): 113-24.
[http://dx.doi.org/10.1016/0891-5849(88)90036-6] [PMID: 3075947]
[67]
Baynes JW, Thorpe SR. The role of oxidative stress in diabetic complications. Curr Opin Endocrinol Diabetes 1996; 3(4): 277-84.
[http://dx.doi.org/10.1097/00060793-199608000-00001]
[68]
Lipinski B. Pathophysiology of oxidative stress in diabetes mellitus. J Diabetes Complications 2001; 15(4): 203-10.
[http://dx.doi.org/10.1016/S1056-8727(01)00143-X] [PMID: 11457673]
[69]
Vasudevan M, Parle M. Pharmacological actions of Thespesia populnea relevant to Alzheimer’s disease. Phytomedicine 2006; 13(9-10): 677-87.
[http://dx.doi.org/10.1016/j.phymed.2006.01.007] [PMID: 16860552]
[70]
Kupfermann I. Learning and memory. In: Principles of Neural Science. Kandel ER, Schwartz JH, Jessell TM, eds. London: Prentice Hall International 1993.
[71]
Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer’s disease: A review of progress. J Neurol Neurosurg Psychiatry 1999; 66(2): 137-47.
[http://dx.doi.org/10.1136/jnnp.66.2.137] [PMID: 10071091]
[72]
Joshi H, Megeri K, Bidchol MA, Kulkarni VH. Clerodendron phlomidis Linn improves short term memory of chemically and naturally induced amnesia in mice. Nat Prod 2007; 3(3): 166-70.
[73]
Kim DH, Yoon BH, Kim YW, et al. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J Pharmacol Sci 2007; 105(1): 82-93.
[http://dx.doi.org/10.1254/jphs.FP0061565] [PMID: 17895591]
[74]
Beers MH. The Merck manual of medical information. (2nd ed.), New Jersey: Merck and Co, INC 2003.
[75]
Oliveira DR, Sanada PF, Saragossa FAC, et al. Neuromodulatory property of standardized extract Ginkgo biloba L. (EGb 761) on memory: Behavioral and molecular evidence. Brain Res 2009; 1269: 68-89.
[http://dx.doi.org/10.1016/j.brainres.2008.11.105] [PMID: 19146837]
[76]
Howes MJR, Houghton PJ. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 2003; 75(3): 513-27.
[http://dx.doi.org/10.1016/S0091-3057(03)00128-X] [PMID: 12895669]
[77]
Oh MS, Huh Y, Bae H, Ahn DK, Park SK. The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus. Neurosci Lett 2005; 379(3): 205-8.
[http://dx.doi.org/10.1016/j.neulet.2004.12.077] [PMID: 15843064]
[78]
Govindarajan R, Vijayakumar M, Pushpangadan P. Antioxidant approach to disease management and the role of ‘Rasayana’ herbs of Ayurveda. J Ethnopharmacol 2005; 99(2): 165-78.
[http://dx.doi.org/10.1016/j.jep.2005.02.035] [PMID: 15894123]
[79]
Joshi H, Parle M. Zingiber officinale: Evaluation of its nootropic effect in mice. Afr J Tradit Complement Altern Med 2006; 3(1): 64-74.
[80]
Topic B, Tani E, Tsiakitzis K, et al. Enhanced maze performance and reduced oxidative stress by combined extracts of Zingiber officinale and Ginkgo biloba in the aged rat. Neurobiol Aging 2002; 23(1): 135-43.
[http://dx.doi.org/10.1016/S0197-4580(01)00241-X] [PMID: 11755028]
[81]
Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. Ginger extract inhibits beta-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med 2004; 10(6): 1009-13.
[http://dx.doi.org/10.1089/acm.2004.10.1009] [PMID: 15673995]
[82]
Abdelazim A, Khater S, Ali H, et al. Panax ginseng improves glucose metabolism in streptozotocin-induced diabetic rats through 5′ adenosine monophosphate kinase up-regulation. Saudi J Biol Sci 2019; 26(7): 1436-41.
[http://dx.doi.org/10.1016/j.sjbs.2018.06.001] [PMID: 31762606]
[83]
Abdel-Zaher AO, Farghaly HSM, El-Refaiy AEM, Abd-Eldayem AM. Protective effect of the standardized leaf extract of Ginkgo biloba (EGb761) against hypertension-induced renal injury in rats. Clin Exp Hypertens 2018; 40(8): 703-14.
[http://dx.doi.org/10.1080/10641963.2018.1425421] [PMID: 29351002]
[84]
Abegaz TM, Tefera YG, Befekadu Abebe T. Target organ damage and the long term effect of nonadherence to clinical practice guidelines in patients with hypertension: A retrospective cohort study. Int J Hypertens 2017; 2017: 1-8.
[http://dx.doi.org/10.1155/2017/2637051] [PMID: 28695006]
[85]
Aday AW, Ridker PM. Antiinflammatory therapy in clinical care: The CANTOS trial and beyond. Front Cardiovasc Med 2018; 5: 62.
[http://dx.doi.org/10.3389/fcvm.2018.00062] [PMID: 29922680]
[86]
Ahmad MF. Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement. Biomed Pharmacother 2018; 107: 507-19.
[http://dx.doi.org/10.1016/j.biopha.2018.08.036] [PMID: 30114634]
[87]
Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379(9811): 165-80.
[http://dx.doi.org/10.1016/S0140-6736(11)60178-5] [PMID: 21840587]
[88]
Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: A review. JAMA 2019; 322(13): 1294-304.
[http://dx.doi.org/10.1001/jama.2019.14745] [PMID: 31573641]
[89]
Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: Report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Kidney Int 2020; 97(6): 1117-29.
[http://dx.doi.org/10.1016/j.kint.2020.02.010]
[90]
Xie Y, Bowe B, Mokdad AH, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 2018; 94(3): 567-81.
[http://dx.doi.org/10.1016/j.kint.2018.04.011] [PMID: 30078514]
[91]
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: Global dimension and perspectives. Lancet 2013; 382(9888): 260-72.
[http://dx.doi.org/10.1016/S0140-6736(13)60687-X] [PMID: 23727169]
[92]
Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: Estimates, variability and pitfalls. Nat Rev Nephrol 2017; 13(2): 104-14.
[http://dx.doi.org/10.1038/nrneph.2016.163] [PMID: 27941934]
[93]
Hoy WE, Kincaid-Smith P, Hughson MD, et al. CKD in Aboriginal Australians. Am J Kidney Dis 2010; 56(5): 983-93.
[http://dx.doi.org/10.1053/j.ajkd.2010.05.010] [PMID: 20728257]
[94]
Zhong Y, Deng Y, Chen Y, Chuang PY, Cijiang He J. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int 2013; 84(6): 1108-18.
[http://dx.doi.org/10.1038/ki.2013.276] [PMID: 23868014]
[95]
Gobe GC, Wojcikowski K. Nontraditional (non-Western pharmaceutical) treatments for chronic kidney disease. Clin Nephrol 2020; 93(1): 49-54.
[http://dx.doi.org/10.5414/CNP92S108] [PMID: 31829927]
[96]
Wojcikowski J, Nowicki M, Gulec M. The effect of Astragalus membranaceus and enalapril on renal fibrosis in rats with unilateral ureteral obstruction. Planta Med 2016; 82 (Suppl. 1): S1-S381.
[http://dx.doi.org/10.1055/s-0036-1596330]
[97]
Schnaper HW. The tubulointerstitial pathophysiology of progressive kidney disease. Adv Chronic Kidney Dis 2017; 24(2): 107-16.
[http://dx.doi.org/10.1053/j.ackd.2016.11.011] [PMID: 28284376]
[98]
Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol 2014; 10(9): 493-503.
[http://dx.doi.org/10.1038/nrneph.2014.114] [PMID: 24981817]
[99]
Djudjaj S, Boor P. Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 2019; 65: 16-36.
[http://dx.doi.org/10.1016/j.mam.2018.06.002] [PMID: 29909119]
[100]
Thorpe KE. The role of chronic disease and multiple chronic conditions on the level and change in per capita health care spending, 2010-2021. J Chronic Dis Manag 2024; 8(1): 1035.https://www.jscimedcentral.com/public/assets/articles/chronicdiseases-8-1035.pdf
[101]
Ashande MC, Mpiana PT. Ethno-botany and pharmacognosy of Ageratum conyzoides L. J Adv Med Life Sci 2015; 2(4): 1-6.
[102]
de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 2022; 45(12): 3075-90.
[http://dx.doi.org/10.2337/dci22-0027] [PMID: 36189689]
[103]
Rojas JC, Chokkara S, Zhu M, Lindenauer PK, Press VG. Care quality for patients with chronic obstructive pulmonary disease in the readmission penalty era. Am J Respir Crit Care Med 2023; 207(1): 29-37.
[http://dx.doi.org/10.1164/rccm.202203-0496OC] [PMID: 35916652]
[104]
Albogami Y, Cusi K, Daniels MJ, Wei YJJ, Winterstein AG. Response to comment on Albogami et al. Glucagon-like peptide-1 receptor agonists and chronic lower respiratory disease exacerbations among patients with type 2 diabetes. Diabetes Care 2021; 44(8): e167.
[http://dx.doi.org/10.2337/dci21-0024] [PMID: 34285101]
[105]
Lukman NA, Leibing A, Merry L. Self-care experiences of adults with chronic disease in Indonesia: An integrative review. Int J Chronic Dis 2020; 2020: 1-17.
[http://dx.doi.org/10.1155/2020/1379547] [PMID: 32908858]
[106]
Alkaff FF, Illavi F, Salamah S, et al. The impact of the Indonesian Chronic Disease Management Program (PROLANIS) on metabolic control and renal function of type 2 diabetes mellitus patients in primary care setting. J Prim Care Community Health 2021; 12.
[http://dx.doi.org/10.1177/2150132720984409] [PMID: 33472499]
[107]
Gallo A, Covino M, Lipari A, et al. Increase in chronic medications and polypharmacy-the multifaceted burden of COVID-19 disease on public health care. J Pers Med 2023; 13(9): 1321.
[http://dx.doi.org/10.3390/jpm13091321] [PMID: 37763088]
[108]
Lin CY, Gentile NL, Bale L, et al. Implementation of a physical activity vital sign in primary care: Associations between physical activity, demographic characteristics, and chronic disease burden. Prev Chronic Dis 2022; 19: 210457.
[http://dx.doi.org/10.5888/pcd19.210457] [PMID: 35749145]

Rights & Permissions Print Cite
Article Metrics
Pdf icon 25
Html icon 2
Find your institution